...
首页> 外文期刊>Seminars in Thrombosis and Hemostasis >Mixing tests: Diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times
【24h】

Mixing tests: Diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times

机译:混合试验:诊断助手,用于研究凝血酶原时间延长和活化部分凝血活酶时间延长

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mixing tests are a relatively simple procedure used in the hemostasis laboratory as a first-line investigation into the cause of an abnormal screening test, typically a prolonged activated partial thromboplastin time and/or a prolonged prothrombin time. The mixing test involves combining the test plasma with normal plasma, then repeating the screening test on the mixture to assess whether the clotting time becomes normal or remains prolonged. The primary purpose of a mixing test is to guide further investigations. When mixing test results "normalize,o" this suggests the test plasma is deficient in clotting factor(s) and thus specific factor assays can be performed to determine which are reduced. When the mixing test result does not "normalize,o" this suggests the presence of an inhibitor or other type of interference (e.g., the presence of an anticoagulant such as high-dose heparinoids), and so the laboratory needs to determine if this is a lupus anticoagulant or a specific coagulation factor inhibitor, or another type of inhibitor. Because these follow-up investigations are more costly and time-consuming than the basic screening tests, the appropriate performance and interpretation of mixing tests is advantageous for the laboratory. Moreover, the correct laboratory approach is also clinically relevant, as patient management is ultimately affected, and an incorrect interpretation may lead to inappropriate therapies being established. Components of a mixing test that can influence result interpretation include the sensitivity of the used screening reagents to various factor deficiencies and inhibitors, the source or composition of the normal plasma, and the setting of cutoffs for the formula used in expressing mixing test results. Numerous and differing criteria for mixing test interpretation have been suggested historically, which can lead to confusion as to which approach is the most appropriate. The use of differing criteria will also lead to differing interpretations regarding "normalization.o" For this pivotal reason, standardized mixing test procedures and a consistent set of validated interpretive criteria represent the most favorable approach to maximizing the utility of a mixing test, and ensure the most accurate diagnosis for investigated patients.
机译:混合测试是止血实验室中使用的相对简单的程序,可作为一线调查异常筛查测试的原因,通常是活化的部分凝血活酶时间延长和/或凝血酶原时间延长。混合测试包括将测试血浆与正常血浆混合,然后对混合物重复进行筛选测试,以评估凝结时间是否正常或保持较长时间。混合测试的主要目的是指导进一步的研究。当混合测试结果“归一化”时,这表明测试血浆缺乏凝血因子,因此可以进行特异性因子测定以确定减少的因子。当混合测试结果未“正常化”时,这表明存在抑制剂或其他类型的干扰(例如,存在抗凝剂,例如大剂量类肝素),因此实验室需要确定这是否是狼疮抗凝剂或特定凝血因子抑制剂,或另一种抑制剂。因为这些后续调查比基本的筛查测试更加昂贵和耗时,所以适当的性能和混合测试的解释对实验室是有利的。此外,正确的实验室方法在临床上也很重要,因为最终会影响患者的管理,并且错误的解释可能会导致建立不合适的疗法。可能影响结果解释的混合测试的组成部分包括:所用筛选试剂对各种因子缺陷和抑制剂的敏感性,正常血浆的来源或组成,以及用于表达混合测试结果的配方的临界值。历史上已经提出了许多不同的混合测试解释标准,这可能导致混淆哪种方法最合适。使用不同的标准也将导致对“ normalization.o”的不同解释。出于这个关键原因,标准化的混合测试程序和一致的一组经过验证的解释性标准是最大化混合测试实用性的最有利方法,并确保最适合被调查患者的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号